In the midst of Corona's growing contraction, the good news is coming. The corona vaccine COVAXIN could be launched on August 15. The vaccine has been developed by pharmaceutical company Bharat Biotech. Vaccination from India Biotech and ICMR is possible. Covaxin has recently received approval for a human trial. According to a letter submitted by ICMR, enrollment for the human trial will start from July 7. After this, if all the trials prove to be correct then hopefully by August 15, the covaxin will be launched. India may be the first to enter the biotech vaccine market. 

Hyderabad-based pharma company Bharat Biotech recently claimed that it had also received a green signal from DCGI for Phase-1 and Phase-2 human trials of Covaxin. The company also said that trial work would begin in the first week of July. India has a long experience of making biotech vaccines. Bharat Biotech has also developed vaccines for polio, rabies, rotavirus, Japanese encephalitis, chikungunya, and Zika virus. Enrollment for the humanitarian trial could begin July 7. After this, a phased trial will be started. If the trial is successful, the vaccine will be launched on August 15.